Dealing with research misconduct in the United Kingdom. An American perspective on research integrity
- PMID: 9614029
- PMCID: PMC1113279
- DOI: 10.1136/bmj.316.7146.1726
Dealing with research misconduct in the United Kingdom. An American perspective on research integrity
Comment in
-
Fraud. Pharmaceutical industry follows guidelines on conduct of research.BMJ. 1998 Dec 5;317(7172):1590. BMJ. 1998. PMID: 9890768 No abstract available.
-
Fraud. Fraud at conferences needs to be addressed.BMJ. 1998 Dec 5;317(7172):1591. BMJ. 1998. PMID: 9890770 No abstract available.
-
Fraud. Some aspects do not fall within remit of bodies examining fraud.BMJ. 1998 Dec 5;317(7172):1591. BMJ. 1998. PMID: 9890771 No abstract available.
References
-
- Broad W, Wade N. Betrayers of the truth. New York: Simon and Schuster; 1982.
-
- Relman AS. Lessons from the Darsee affair. N Engl J Med. 1983;308:1415–1417. - PubMed
-
- Rennie D, Gunsalus CK. Scientific misconduct. New definition, procedures, and office—perhaps a new leaf. JAMA. 1993;269:915–917. - PubMed
-
- Gunsalus CK. Preventing the need for whistleblowing: practical advice for university administrators. Sci Eng Ethics. 1998;4:75–84.
-
- Commission on Research Integrity. Integrity and misconduct in research. Report of the Commission on Research Integrity to the Secretary of Health and Human Services, the House Committee on Commerce and the Senate Committee on Labor and Human Resources. Rockville, MD: US Department of Health and Human Services, Public Health Service; 1995.
MeSH terms
LinkOut - more resources
Full Text Sources